Abstract:There is increasing interest in changing the emphasis of tumor classification from morphologic to molecular. Gene expression profiles may offer more information than morphology and provide an alternative to morphology-based tumor classification systems. Gene selection involves a search for gene subsets that are able to discriminate tumor tissue from normal tissue, and may have either clear biological interpretation or some implication in the molecular mechanism of the tumorigenesis. Gene selection is a fundamental issue in gene expression-based tumor classification. In the formation of a discriminant rule, the number of genes is large relative to the number of tissue samples. Too many genes can harm the performance of the tumor classification system and increase the cost as well. In this report, we discuss criteria and illustrate techniques for reducing the number of genes and selecting an optimal (or near optimal) subset of genes from an initial set of genes for tumor classification. The practical advantages of gene selection over other methods of reducing the dimensionality (e.g., principal components), include its simplicity, future cost savings, and higher likelihood of being adopted in a clinical setting. We analyze the expression profiles of 2000 genes in 22 normal and 40 colon tumor tissues, 5776 sequences in 14 human mammary epithelial cells and 13 breast tumors, and 6817 genes in 47 acute lymphoblastic leukemia and 25 acute myeloid leukemia samples. Through these three examples, we show that using 2 or 3 genes can achieve more than 90% accuracy of classification. This result implies that after initial investigation of tumor classification using microarrays, a small number of selected genes may be used as biomarkers for tumor classification, or may have some relevance in tumor development and serve as a potential drug target. In this report we also show that stepwise Fisher's linear discriminant function is a practicable method for gene expression-based tumor classification.

RankGene: Identification of Diagnostic Genes Based on Expression Data.

Rank Sum Method for Related Gene Selection and Its Application to Tumor Diagnosis

A Rank Sum Test Method for Informative Gene Discovery.

Gene Ranking Using R-Metric

Rank-in: Enabling Integrative Analysis Across Microarray and RNA-seq for Cancer

A Comparative Analysis of Gene Expression Profiling by Statistical and Machine Learning Approaches

GeneRaMeN enables integration, comparison, and meta-analysis of multiple ranked gene lists to identify consensus, unique, and correlated genes

Understanding the GeneRank Model

RankByGene: Gene-Guided Histopathology Representation Learning Through Cross-Modal Ranking Consistency

Ensemble methods of rank-based trees for single sample classification with gene expression profiles

GroupRank: Rank Candidate Genes in PPI Network by Differentially Expressed Gene Groups.

Significance of gene ranking for classification of microarray samples.

Krylov subspace algorithms for computing GeneRank for the analysis of microarray data mining.

Feature (gene) Selection in Gene Expression-Based Tumor Classification

Disease Gene Identification Based on Singular Value Decomposition

Use of relevancy and complementary information for discriminatory gene selection from high-dimensional cancer data

An Information Criterion for Informative Gene Selection

Netrank: network-based approach for biomarker discovery

Individual-level analysis of differential expression of genes and pathways for personalized medicine

A Novel Similarity Score Based on Gene Ranks to Reveal Genetic Relationships among Diseases

Robust model-based clustering with gene ranking